Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.2K Hold
1,095
﹤0.01% 1713
2026
Q1
$16K Buy
1,095
+143
+15% +$2.1K ﹤0.01% 1923
2025
Q4
$12K Sell
952
-1,037
-52% -$15.3K ﹤0.01% 1914
2025
Q3
$30.6K Buy
1,989
+157
+9% +$2.53K ﹤0.01% 1322
2025
Q2
$28.8K Buy
1,832
+1,794
+4,721% +$27.2K ﹤0.01% 1311
2025
Q1
$726 Buy
+38
New +$831 ﹤0.01% 2391
2024
Q2
Sell
-420
Closed -$9.19K 2000
2024
Q1
$9.19K Hold
420
﹤0.01% 810
2023
Q4
$9.77K Buy
+420
New +$8.45K ﹤0.01% 754
2023
Q3
Sell
-548
Closed -$12.4K 2039
2023
Q2
$12.4K Buy
+548
New +$11K ﹤0.01% 683

Other funds holding RXO

Versant Capital Management's RXO Position: Q2 2026 in Review

Versant Capital Management held its RXO (RXO) position steady in Q2 2026 at 1,095 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Versant Capital Management first reported a position in RXO in Q2 2023 and has held it in 9 quarters since. The position peaked at $30.6K in Q3 2025. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Versant Capital Management held 1,095 shares of RXO worth $30.2K as of Q2 2026.
  • Versant Capital Management left its RXO share count unchanged in Q2 2026.
  • RXO made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1713 holding.
  • Versant Capital Management first reported a position in RXO in Q2 2023 and has held it in 9 quarters since.
  • Versant Capital Management's RXO position peaked at $30.6K in Q3 2025.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.